.75 mg semaglutide Obesity drug Wegovy reduces cardiovascular risks for those at high risk and increasing feelings of fullness Researchers found that 32% of

Approval of Hympavzi was supported by data from the Phase III BASIS trial, which enrolled nearly 190 patients with severe hemophilia A or moderately severe to severe hemophilia B

Stress and melanocyte stimulating hormone Chronic stress raises plasma -melanocyte-stimulating hormone levels, with one study finding 17.9 pg/mL in chronic stress patients versus 14.5 pg/mL in healthy controls [41]

*Efficacy and Safety of Semaglutide 7.2 mg in Obesity STEP UP Trial.* Diabetes

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation, weight rebound potential, and metabolic adaptation